Experimental models of sepsis and septic shock: an overview
Sepsis remains a major cause of morbidity and mortality in surgical patients and trauma victims, mainly due to sepsis-induced multiple organ dysfunction. In contrast to preclinical studies, most clinical trials of promising new treatment strategies for sepsis have fails to demonstrate efficacy. Although many reasons could account for this discrepancy, the misinterpretation of preclinical data obtained from experimental studies, and especially the use of animal models that do not adequately mimic human sepsis may have been contributing factors. In this review, the benefits and limitations of various animal models of sepsis are discussed to clarify the extend to which findings are relevant to human sepsis, particularly with respect to the subsequent design and execution of clinical trials. Such models include intravascular infusion of endotoxin or live bacteria, bacterial peritonitis, cecal ligation and perforation, soft tissue infection, pneumonia or meningitis models, using different animal species including rats, mice, rabbits, dogs, pigs, sheep and nonhuman primates. Despite several limitations, animal models remain essential in the development of all new therapies for sepsis and septic shock, because they provide fundamental information about the pharmacokinetics, toxicity, and mechanism of drug action that cannot be duplicated by other methods. New therapeutic agents should be studies in infection models, even after the initiation of the septic process. Furthermore, debility conditions need to be reproduced to avoid the exclusive use of healthy animals, which often do not represent the human septic patient.
Main Authors: | Garrido,Alejandra G., Figueiredo,Luiz Francisco Poli de, Silva,Maurício Rocha e |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia
2004
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-86502004000200001 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence and factors associated with sepsis and septic shock in oncological patients in intensive therapy
by: Silva,Miriam Maria Mota, et al.
Published: (2022) -
The impact of duration of organ dysfunction on the outcome of patients with severe sepsis and septic shock
by: Freitas,Flávio G. R., et al.
Published: (2008) -
Overexpression of miR-451a in sepsis and septic shock patients is involved in the regulation of sepsis-associated cardiac dysfunction and inflammation
by: Wang,Heng, et al.
Published: (2020) -
Comparative analysis of survival between elderly and non-elderly severe sepsis and septic shock resuscitated patients
by: Palomba,Henrique, et al.
Published: (2015) -
Procalcitonin determined at emergency department as an early indicator of progression to septic shock in patient with sepsis associated with ureteral calculi
by: Ko,Young Hwii, et al.
Published: (2016)